Haematology

The Department of Hematology at Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine originated from the Hematology Group of the Department of Internal Medicine, established in the 1950s and 1960s. Through the continuous and in-depth development led by renowned Traditional Chinese Medicine hematology physicians and experts such as Wu Hanxiang, Wu Zhengxiang and Qiu Zhongchuan, it gradually developed into the present-day Department of Hematology. The department adheres to a development approach centered on Traditional Chinese Medicine (TCM) and integrating TCM with Western medicine, with medical care at its core and medical care, teaching and research integrated, focusing on its key areas, leveraging its specialty strengths, carrying forward the distinctive experience of TCM, innovatively developing the academic system of TCM hematology, using clinical research as the driving force to advance basic research and new drug development, closely integrating clinical practice with societal needs, continuously improving diagnostic and treatment techniques, and refining an approach guided by syndrome differentiation and treatment that combines “disease differentiation” and “syndrome differentiation.” The discipline has distinctive TCM characteristics, a high level of diagnostic and treatment expertise, and strong innovation capabilities; its ability to diagnose and treat hematological diseases and provide emergency care for critical and severe illnesses has reached a high level, and it has reached a leading level in China in TCM academic research and the clinical treatment of myelodysplastic syndrome, immune-related thrombocytopenia, aplastic anemia, acute leukemia, lymphoma, multiple myeloma and other hematological diseases, and has published nearly 80 papers in domestic and international core journals. It has led and completed nearly 10 national-level and municipal bureau-level clinical research projects. It is a department participating in the TCM specialty and thrombocytopenia disease-specific cultivation programs of the Shanghai Municipal Health Commission. The department has successively developed the in-house preparations “Jiawei Guipi Mixture” and “Zidian Mixture” for treating thrombocytopenia, and “Compound Shenlu Granules” for treating aplastic anemia and myelodysplastic syndrome, all of which have achieved very good clinical efficacy.